midkine conference, page-8

Dr Takashi Muramatsu, Aichi Gakuin University, Aichi, Japan

Eventually Dr Takashi Muramatsu is author and co-author of many earth shaking journal articles on Midkine, the growth enhancer protein that alarms cancer problem of many types when exists excessively in blood.
1. Muramatsu, T. (2002) Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis. J. Biochem 132, 359-371. ?mhttp://jb.oxfordjournals.org/cgi/reprint/132/3/359?n

2. Muramatsu, T. (2002) Midkine in Wiley Encyclopedia of Molecular Medicine pp2086-2088. John Wiley & Sons., Inc. New York, USA

3. Muramatsu, T. Chondroitin sulfate E in signaling of the growth factor midkine.?@?mhttp://www.glycoforum.gr.jp/science/glycogenes/09/09E.html?n
....
6. Kadomatsu, K., and Muramatsu, T. (2004) Midkine and pleiotrophin in neural development and cancer. Cancer Lett. 204, 127-143.

7. Muramatsu T, Muramatsu H, Kaneda N, Sugahara K. (2003) Recognition of glycosaminoglycans by midkine. Methods Enzymol. 363, 365-376.

(Now I know how the Japanese technologists can put their scientific knowledge into application by inventing hair growth lotion.)

I wish the conference all the best. Midkine is a marker for cancer and a number of other diseases, and it is also a target for therapy of cancer and other diseases ... So, I hope CDY MK Elisa test kit will be accepted as the best one on the market after the conference by many experts on Midkine all around the world. It will take time for CDY test kit and other CDY Midkine-based products to make inroads into the market but the light is getting brighter and brighter at end of the tunnel for patients as well as for CDY s/holders if this CDY conference is successful.